Compare Cytokinetics Inc (CYTK) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Western Alliance Bancorporation — how do they compare? Cytokinetics Inc trades at $81.99 (market cap $11.16B), while Western Alliance Bancorporation trades at $80.41 (market cap $8.79B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Western Alliance Bancorporation pays a 2.09% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | WAL | |
|---|---|---|
Market Cap | $11.16B | $8.79B |
Sector | Technology | Financials |
52-Week High | $87.26 | $96.08 |
52-Week Low | $33.23 | $66.70 |
Enterprise Value | $11.63B | — |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
